Biotech Values

[xavierprivas]

According to the clinicaltrials site

Primary Completion Date: June 27, 2017 (Final data collection date for primary outcome measure)

https://clinicaltrials.gov/ct2/show/NCT02358538?term=ganaxolone&rank=3

IMO may be some info leaked from the study. I noticed that Deerfield
acquired 9.98% 2.238 M sh of MRNS on 7/14/17 and reported it 7/17/17

Also EcoR1 acquired 12.2% 3,622,271 sh of MRNS on 8/4/17 reported it 8/8/17

It is an open label study so it may not be a definite proof of ganaxolone
efficacy but for a penny stock like MRNS it could be a big bump.
I believe SAGE is a better buy in the long term. In early July before
these hedge funds purchase the stock languished around $1.30-$1.40